Cargando…

Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy

Chronic lymphocytic leukemia (CLL) displays an extremely variable clinical behaviour. Accurate prognostication and prediction of response to treatment are important in an era of effective first-line regimens and novel molecules for high risk patients. Because a plethora of prognostic biomarkers were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martinelli, Sara, Cuneo, Antonio, Formigaro, Luca, Cavallari, Maurizio, Lista, Enrico, Quaglia, Francesca Maria, Ciccone, Maria, Bardi, Antonella, Volta, Eleonora, Tammiso, Elisa, Saccenti, Elena, Sofritti, Olga, Daghia, Giulia, Negrini, Massimo, Dabusti, Melissa, Tomasi, Paolo, Moretti, Sabrina, Cavazzini, Francesco, Rigolin, Gian Matteo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5111525/ https://www.ncbi.nlm.nih.gov/pubmed/27872727 http://dx.doi.org/10.4084/MJHID.2016.047

Ejemplares similares

Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia
por: Cavallari, Maurizio, et al.
Publicado: (2018)

Modern treatment in chronic lymphocytic leukemia: impact on survival and efficacy in high-risk subgroups
por: Cuneo, Antonio, et al.
Publicado: (2014)

Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations
por: Rigolin, Gian Matteo, et al.
Publicado: (2016)

Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations
por: Rigolin, Gian Matteo, et al.
Publicado: (2016)

An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness
por: Rigolin, Gian Matteo, et al.
Publicado: (2017)

Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in Splenic Marginal Zone Lymphoma
por: Bardi, Antonella, et al.
Publicado: (2011)

Genetic subclonal complexity and miR125a-5p down-regulatio identify a subset of patients with inferior outcome in low-ris CLL patients
por: Rigolin, Gian Matteo, et al.
Publicado: (2013)

Response to Ibrutinib of a Refractory IgA Lymphoplasmacytic Lymphoma Carrying the MYD88 L265P Gene Mutation
por: Quaglia, Francesca Maria, et al.
Publicado: (2019)

Delirium in acute promyelocytic leukemia patients: two case reports
por: Rigolin, Gian Matteo, et al.
Publicado: (2013)

“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia”
por: Cavallari, Maurizio, et al.
Publicado: (2017)

A Tangle of Genomic Aberrations Drives Multiple Myeloma and Correlates with Clinical Aggressiveness of the Disease: A Comprehensive Review from a Biological Perspective to Clinical Trial Results
por: Sessa, Mariarosaria, et al.
Publicado: (2020)

MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia
por: Ferracin, Manuela, et al.
Publicado: (2010)

The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation
por: Visentin, Andrea, et al.
Publicado: (2021)

The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia
por: Visentin, Andrea, et al.
Publicado: (2019)

First-Line Treatment of Older Patients with CLL: A New Approach in the Chemo-Free Era
por: Urso, Antonio, et al.
Publicado: (2023)

Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death
por: Salaro, Erica, et al.
Publicado: (2016)

Genomic arrays for the identification of high-risk chronic lymphocytic leukemia: ready for prime time?
por: Cuneo, Antonio, et al.
Publicado: (2021)

Hsa-miR-15a and Hsa-miR-16-1 Expression Is Not Related to Proliferation Centers Abundance and Other Prognostic Factors in Chronic Lymphocytic Leukemia
por: Rossi, Maura, et al.
Publicado: (2013)

Right Atrium Mass Assessed with 18F-FDG PET/CT Scan Turns Out to Be an Uncommon Relapse of Testicular Diffuse Large B-cell Lymphoma: A Case Report
por: Panareo, Stefano, et al.
Publicado: (2020)

Old and New Drugs for Chronic Lymphocytic Leukemia: Lights and Shadows of Real-World Evidence
por: Marchetti, Monia, et al.
Publicado: (2022)

Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia
por: Voltan, Rebecca, et al.
Publicado: (2016)

Treatment with ibrutinib does not induce a TP53 clonal evolution in chronic lymphocytic leukemia
por: Cafforio, Luciana, et al.
Publicado: (2021)

Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report
por: Cuneo, Antonio, et al.
Publicado: (2020)

Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3
por: Agnoletto, Chiara, et al.
Publicado: (2014)

The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway
por: Agnoletto, Chiara, et al.
Publicado: (2014)

Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group
por: Rigolin, Gian Matteo, et al.
Publicado: (2021)

Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer
por: Zoratto, Federica, et al.
Publicado: (2012)

Critical appraisal of the literature
por: FERREIRA, ÁLIDA ROSÁRIA SILVA, et al.
Publicado: (2021)

Appraisal
por: Peters, Andreas Joachim
Publicado: (2020)

Modulated expression of adhesion, migration and activation molecules may predict the degree of response in chronic lymphocytic leukemia patients treated with ibrutinib plus rituximab
por: Peragine, Nadia, et al.
Publicado: (2020)

COVID-19: Critical appraisal of the evidence()
por: González Rodríguez, Paz, et al.
Publicado: (2021)

Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patients
por: De Matteis, Serena, et al.
Publicado: (2018)

Critical appraisal of the use of regorafenib in the management of colorectal cancer
por: Festino, Lucia, et al.
Publicado: (2013)

Misinterpretation of an inflammatory FDG uptake in a patient treated for Hodgkin lymphoma: a case report
por: Nieri, Alberto, et al.
Publicado: (2023)

Subjective Appraisal and Orientations in Difficult Life Situations as Predictors of Coping Strategies
por: Bityutskaya, Ekaterina V., et al.
Publicado: (2021)

The p53 transcriptional pathway is preserved in ATM(mutated) and NOTCH1(mutated) chronic lymphocytic leukemias
por: Athanasakis, Emmanouil, et al.
Publicado: (2014)

COVID-19 and Parkinsonism: A Critical Appraisal
por: Cavallieri, Francesco, et al.
Publicado: (2022)

Using Personal Values to Understand the Motivational Basis of Amity Goal Orientation
por: Levontin, Liat, et al.
Publicado: (2019)

Development and Validation of the Infection Prevention Appraisal Scale
por: Lindberg, Maria, et al.
Publicado: (2023)

An appraisal of oriental theileriosis and the Theileria orientalis complex, with an emphasis on diagnosis and genetic characterisation
por: Gebrekidan, Hagos, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dh0p2h626kpv2vuqmp8u41bgp6